T cell-defined melanoma antigens: toward a tumour-specific immunotherapy of the disease.
Parmiani
G
G
D000951:Antigens, Neoplasm / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology; D015789:HLA-A2 Antigen / Q000276:immunology; D006681:HLA-D Antigens / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D009363:Neoplasm Proteins / Q000276:immunology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*
D000951:Antigens, Neoplasm; D006680:HLA Antigens; D015789:HLA-A2 Antigen; D006681:HLA-D Antigens; D009363:Neoplasm Proteins; D016693:Receptors, Antigen, T-Cell, alpha-beta